Thus, in our study, we found that lncRNA MALAT1 can promote HCC metastasis through peripheral vascular infiltration by inhibiting the levels of miRNA-613, and lncRNA MALAT1 may be a potential target for the treatment of HCC. This evidence concerns the gene MALAT1 and hepatocellular carcinoma.